B
Bonumose
Early-stage food ingredient manufacturer specializing in the affordable production of delicious, good-for-you sugars such as tagatose and allulose
About Bonumose
Bonumose is a biotechnology company specializing in the production of rare sugars, particularly tagatose, through innovative enzymatic processes. The company operates in the health and wellness market, focusing on providing healthier alternatives to traditional sugars. Bonumose's primary clients include food and beverage manufacturers looking to reduce sugar content in their products without compromising taste. The company's business model revolves around scaling up the production of tagatose and other rare sugars to commercial levels, thereby making these healthier sweeteners more accessible and affordable. Revenue is generated through the sale of these rare sugars to manufacturers and potentially through licensing their proprietary enzymatic technology. Bonumose aims to expand its portfolio to include a variety of functional food ingredients, further enhancing its market presence and impact on public health.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Charlottesville, United States
- Employees
- 26
- Open positions
- None listed
- Dealroom signal
- 81.7/100
- Industry
- Food
- Sub-industry
- Innovative Food
- Sector
- Food, Biotechnology, Sugar, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
- Investment activity
- 1 company, latest Oct 2018
- Capital deployed
- $50K
- Preferred round
- CONVERTIBLE
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2023 | $35M | $139M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Jul 2023 | $2M | $8M | Symrise | ↗ |
Growth signals
Latest recorded traffic for Bonumose is 2.9K monthly website visits, up 93.3% over the last three months. Bonumose's team grew 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- CNCharlottesville Angel Network
Series A2 investors entered at this stage
iSelect Fund
Argonautic Ventures
Series B and later1 investor entered at this stage
Symrise
Other known investors5 additional known investors
Virginia Tech College of Engineering- CVCure8 Ventures
- LCLagomaj Capital
Plug and Play
Technology Pioneers | World Economic Forum
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bonumose on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bonumose’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.